US Patent Issued to Decode Health on March 25 for "Long non-coding RNA gene expression signatures in disease monitoring and treatment" (Tennessee Inventor)

ALEXANDRIA, Va., March 26 -- United States Patent no. 12,258,617, issued on March 25, was assigned to Decode Health Inc. (Nashville, Tenn.).

"Long non-coding RNA gene expression signatures in disease monitoring and treatment" was invented by Charles Floyd Spurlock III (Nashville, Tenn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Differential expression of long non-coding RNAs (lncRNAs) and enhancer RNAs (eRNAs) are used to monitor diseases and determine therapeutic efficacy in, for example, neurological diseases, inflammatory diseases, rheumatic diseases, and autoimmune diseases. Machine learning systems are used to identify lncRNAs or eRNAs having differential expression correlated with responsiveness to...